Vera Therapeutics Quarterly Balance Sheet
NASDAQ: VERAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vera Therapeutics financial position
As of Jun 30, 2026, Vera Therapeutics reported total assets of $533.0 million, down 7.9% from a year earlier against total liabilities of $125.2 million. Shareholders' equity stood at $407.8 million, or 76.5% of assets. The company held $48.9 million in cash and equivalents against $75.2 million of debt, a net debt position of $26.4 million.
The current ratio (current assets divided by current liabilities) was 10.92, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.18.
Summary generated from market data by MetaCap's automated system. Methodology
Vera Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 48.88M | 114.35M | 354.73M | 57.77M | 49.12M | 55.09M | 92.65M | 27.26M | 25.09M | 69.11M | 45.68M | 27.44M |
| Short-Term Investments | 450.29M | 482.41M | 359.86M | 439.62M | 507.71M | 534.74M | 548.21M | 326.05M | 359.30M | 334.56M | 115.03M | 132.50M |
| Total Current Assets | 527.49M | 615.80M | 728.88M | 511.31M | 571.35M | 606.08M | 651.22M | 364.13M | 394.75M | 416.37M | 172.02M | 171.62M |
| Property, Plant & Equipment | 813.00K | 945.00K | 1.37M | 1.16M | 1.15M | 1.06M | 960.00K | 368.00K | 155.00K | 81.00K | 92.00K | 34.00K |
| Long-Term Investments | — | — | — | — | — | — | — | — | — | — | 11.00K | 13.00K |
| Total Assets | 532.98M | 621.74M | 734.73M | 517.50M | 578.53M | 610.17M | 655.68M | 368.56M | 397.29M | 419.36M | 175.55M | 175.62M |
| Accounts Payable | 14.57M | 13.91M | 21.90M | 17.95M | 13.16M | 9.26M | 7.67M | 4.60M | 4.66M | 5.21M | 11.12M | 12.30M |
| Total Current Liabilities | 48.32M | 45.15M | 53.45M | 41.88M | 33.55M | 21.89M | 25.37M | 26.46M | 18.42M | 14.54M | 22.30M | 24.62M |
| Long-Term Debt | 75.23M | 75.03M | 74.84M | 74.65M | 74.46M | 50.91M | 50.69M | 50.47M | 50.26M | 50.07M | 49.88M | 25.04M |
| Total Liabilities | 125.23M | 122.04M | 130.21M | 118.62M | 110.25M | 75.17M | 78.53M | 79.50M | 69.42M | 65.81M | 73.86M | 51.91M |
| Shareholders' Equity | 407.76M | 499.70M | 604.52M | 398.88M | 468.28M | 535.00M | 577.15M | 289.06M | 327.87M | 353.54M | 101.69M | 123.71M |
| Retained Earnings | -991.37M | -881.90M | -760.87M | -669.77M | -589.48M | -512.94M | -461.25M | -417.82M | -371.19M | -337.49M | -309.10M | -283.45M |
| Total Debt | 75.23M | 75.03M | 74.84M | 74.65M | 74.46M | 50.91M | 50.69M | 50.47M | 50.26M | 50.07M | 49.88M | 25.04M |
| Net Cash (Debt) | 423.93M | 521.73M | 639.75M | 422.74M | 482.36M | 538.93M | 590.16M | 302.84M | 334.12M | 353.60M | 110.84M | 134.90M |
This table shows 12 quarterly periods of Vera Therapeutics's balance sheet, from Q2 2026 back to Q3 2023, across 14 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow VERA's reporting calendar. What is a balance sheet?